Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$839M |
| 2 |
Amazon
AMZN
|
+$810M |
| 3 |
Tesla
TSLA
|
+$644M |
| 4 |
TSMC
TSM
|
+$546M |
| 5 |
Johnson & Johnson
JNJ
|
+$389M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$891M |
| 2 |
Home Depot
HD
|
+$441M |
| 3 |
JPMorgan Chase
JPM
|
+$335M |
| 4 |
NVO
Novo Nordisk
NVO
|
+$317M |
| 5 |
ASML
ASML
|
+$315M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 20.81% |
| 2 | Technology | 15.51% |
| 3 | Consumer Discretionary | 11.84% |
| 4 | Consumer Staples | 10.09% |
| 5 | Financials | 9.61% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ITI
2551
DELISTED
Iteris, Inc.
ITI
| $967K | ﹤0.01% |
310,985
-125,800
| -29% | -$368K |
|
2552
Invesco Emerging Markets Sovereign Debt ETF
PCY
$1.4B
| $965K | ﹤0.01% |
+51,700
| New | +$935K |
|
2553
Stoke Therapeutics
STOK
$2.06B
| $965K | ﹤0.01% |
104,600
-22,200
| -18% | -$231K |
|
|
MTTR
2554
DELISTED
Matterport, Inc. Class A Common Stock
MTTR
| $963K | ﹤0.01% |
+343,964
| New | +$1.1M |
|
2555
Liberty Latin America Class A
LILA
$1.75B
| $962K | ﹤0.01% |
188,061
+42,541
| +29% | +$217K |
|
2556
Spruce Power Holding Corp
SPRU
$42.2M
| $962K | ﹤0.01% |
130,788
-54,362
| -29% | -$386K |
|
2557
Tarsus Pharmaceuticals
TARS
$2.85B
| $962K | ﹤0.01% |
65,600
-3,900
| -6% | -$64.5K |
|
2558
STAAR Surgical
STAA
$1.15B
| $961K | ﹤0.01% |
19,800
-27,700
| -58% | -$1.74M |
|
|
NAGE
2559
Niagen Bioscience
NAGE
$241M
| $959K | ﹤0.01% |
570,900
-47,310
| -8% | -$75K |
|
2560
MGE Energy Inc
MGEE
$3.05B
| $957K | ﹤0.01% |
13,600
-19,344
| -59% | -$1.33M |
|
2561
First US Bancshares
FUSB
$92.2M
| $956K | ﹤0.01% |
110,121
-12,058
| -10% | -$99.4K |
|
|
TIG
2562
DELISTED
Trean Insurance Group, Inc. Common Stock
TIG
| $956K | ﹤0.01% |
159,300
+87,400
| +122% | +$304K |
|
|
NREF
2563
NexPoint Real Estate Finance
NREF
$332M
| $955K | ﹤0.01% |
60,100
-10,900
| -15% | -$188K |
|
2564
Urban One Class D
UONEK
$24.9M
| $949K | ﹤0.01% |
25,250
-1,500
| -6% | -$66.6K |
|
|
FRGI
2565
DELISTED
Fiesta Restaurant Group, Inc.
FRGI
| $949K | ﹤0.01% |
129,100
-11,800
| -8% | -$78.9K |
|
2566
Lindblad Expeditions
LIND
$2.23B
| $948K | ﹤0.01% |
123,113
+108,113
| +721% | +$913K |
|
2567
Carter Bankshares
CARE
$751M
| $945K | ﹤0.01% |
56,948
+4,948
| +10% | +$86.7K |
|
2568
Larimar Therapeutics
LRMR
$436M
| $945K | ﹤0.01% |
228,774
-67,593
| -23% | -$231K |
|
2569
International Money Express
IMXI
$367M
| $943K | ﹤0.01% |
38,700
-51,100
| -57% | -$1.17M |
|
|
MREO
2570
Mereo BioPharma
MREO
$48.8M
| $943K | ﹤0.01% |
1,257,369
+23,755
| +2% | +$19.5K |
|
2571
Zymeworks
ZYME
$1.7B
| $943K | ﹤0.01% |
120,000
+62,223
| +108% | +$437K |
|
|
CTEV
2572
Claritev Corp
CTEV
$458M
| $942K | ﹤0.01% |
20,470
+3,227
| +19% | +$258K |
|
2573
Robinhood
HOOD
$81.6B
| $941K | ﹤0.01% |
115,600
-18,900
| -14% | -$185K |
|
2574
LENSAR
LNSR
$70.5M
| $939K | ﹤0.01% |
317,395
-14,100
| -4% | -$58.4K |
|
|
AFMD
2575
DELISTED
Affimed
AFMD
| $937K | ﹤0.01% |
75,592
+61,644
| +442% | +$1.08M |
|
Similar funds
Renaissance Technologies's Q4 2022 Portfolio in Review
As of Q4 2022, Renaissance Technologies held 4,601 positions worth $73.1B, up 3.4% from $70.7B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Renaissance Technologies's Q4 2022 filing shows 626 new, 1,390 increased, 2,018 reduced and 524 closed positions. Its largest new stake was Johnson & Johnson: 2,254,125 shares worth $398M. The largest sale was Microsoft, an estimated $891M.
By sector, the portfolio is most concentrated in Healthcare at 21% of assets, up from 19% a quarter earlier, followed by Technology and Consumer Discretionary.
- Renaissance Technologies's largest Q4 2022 buy was Johnson & Johnson: 2,254,125 shares worth $398M.
- Renaissance Technologies added most to Apple in Q4 2022, an estimated $839M increase.
- Renaissance Technologies's biggest Q4 2022 reduction was Novo Nordisk, cutting an estimated $317M.
- Renaissance Technologies fully exited Microsoft in Q4 2022, selling an estimated $891M.
- Renaissance Technologies's ten largest holdings make up 11% of its $73.1B portfolio in Q4 2022.
- Renaissance Technologies opened 626 new positions and closed 524 in Q4 2022.
- Renaissance Technologies's portfolio value rose 3.4% quarter-over-quarter to $73.1B.
Based on Renaissance Technologies's 13F filing for Q4 2022, filed 13 Feb 2023.